Literature DB >> 9203023

Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet's disease.

N Yamashita1.   

Abstract

Neutrophil hyperfunction of Behçet's disease is in part regulated by genetical factors, especially related to HLA-B51 genes and by immunological abnormalities. Regarding the latter points, Behçet's disease worsens with abnormal regulation by gamma delta T cells and alpha beta T cells. Indeed, our own studies and those of other laboratories suggest that human heat shock protein may be one of the triggering factors for activation of both the gamma delta T cells and alpha beta T cells. These activated T cells may produce proinflammatory and/or inflammatory cytokines, and lead to tissue injury possibly via delayed-type hypersensitivity reaction, macrophage activation, and activation and/or recruitment of neutrophils. Here we discuss the crosstalk between the immune system and neutrophils in this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203023     DOI: 10.3109/08830189709116841

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  3 in total

Review 1.  The role of chemokines and their receptors in uveitis.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Ghislain Opdenakker; Karel Geboes; Jo Van Damme
Journal:  Int Ophthalmol       Date:  2007-03-13       Impact factor: 2.031

2.  Assessment of Cytokine Release against Oral Mucosal Cell Line Culture (TR146) Stimulated by Neutrophil Elastase Associated with Behcet's Disease.

Authors:  Azeem Hussain Soomro; Erum Khan; Shafaq Noori; Mohid Abrar Lone; Zahid Syal; Sabir Sheikh
Journal:  Int J Dent       Date:  2019-05-26

3.  Novel Insights Into Gene Signatures and Their Correlation With Immune Infiltration of Peripheral Blood Mononuclear Cells in Behcet's Disease.

Authors:  Haoting Zhan; Haolong Li; Linlin Cheng; Songxin Yan; Wenjie Zheng; Yongzhe Li
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.